ACS Chemical Biology, ACS Chemical Neuroscience, ACS infectious diseases, Medicinal Chemistry ACS Letters, ACS Pharmacology and Translation Studies, and Journal of Medicinal Chemistry invite the biomedical research community to submit manuscripts for a joint virtual special edition 2022 on advances in epigenetics.
This is a continuation of a much-read and much-cited joint special edition on the same topic published in 2016 by. has been published ACS Chemical Biology, Medicinal Chemistry ACS Letters, biochemistry, and Journal of Medicinal Chemistry.
This joint virtual special issue highlights the broad spectrum of research activities and services in this exciting field of study. Each journal will focus on a different aspect of epigenetics and will be guided by selected guest editors.
Each manuscript is initially published in a regular edition shortly after it is accepted for publication. Once all contributions have been accepted, they will be collected on a single website to additionally showcase the work of each author. This website will be announced in another regular issue, which will contain an introductory editorial by the guest editorial team.
Read on to learn more about the types of manuscripts each participating journals are looking for and check out the submission deadlines.
ACS Chemical Biology
Deadline: October 1, 2021
Guest Editor: Jordan Meier, (US) National Cancer Institute
ACS Chemical Biology welcomes submissions that use chemical biology approaches or describe new chemical-biological tools to understand or use epigenetic mechanisms or functions.
During the submission process, please select the tag “Epigenetics 2022” in the drop-down menu for the special edition to mark your manuscript for inclusion in the edition. Please note that all submissions will be subjected to the standard peer review process.
We look forward to reading about your latest research, and thank you for supporting our journal and the chemical biology research community!
LEARN MORE: Read ACS Chemical Biology‘s Call for Papers Editorial
If you have any questions, please send an email to email@example.com.
ACS Chemical Neuroscience
Deadline: October 1, 2021
Guest Editor: Stephan J. Haggarty, Harvard Medical School, Massachusetts General Hospital, Broad Institute of MIT & Harvard
ACS Chemical Neuroscience will focus on epigenetic mechanisms associated with neurogenesis, neural plasticity, and cognition and memory. Interesting work also includes those targeting neuropsychiatric disorders in which epigenetic deregulation is a major driver of the disease phenotype. Articles, letters, perspectives, and reviews are welcome.
Please mark your manuscript by selecting “Epigenetics 2022” from the special edition drop-down menu during submission.
We look forward to reading of your latest research, and thank you for supporting our journal and the chemical neuroscience research community!
If you have any questions, please send an email to firstname.lastname@example.org.
ACS infectious diseases
Deadline: December 31, 2021
Guest Editors: Associate Editor Félix Calderón, GlaxoSmithKline; Kelly Chibale, University of Cape Town; and Nathaniel G. Jones, University of York;
ACS infectious diseases invites submissions of articles, letters, reviews, positions and perspectives from academic groups, nonprofits and industry In recognition of the breadth of research that epigenetics can encompass, we reflect this with broad interest. This includes work on the genetic and chemical target validation of histone-modifying enzymes of pathogens, reader proteins of these modifications, targeting of the host response to pathogens, virulence factors of pathogens that influence human epigenetic processes, host-pathogen interactions, epi-transcriptomics, platforms for drug discovery, experimental Model systems, mechanistic characterizations, approaches using biologics, natural products and synthetic small molecules. We are open to work that describes the biology of viral, bacterial and eukaryotic pathogens in detail.
LEARN MORE: Read ACS infectious diseases‘Call for Papers Editorial
If you have any questions, please send an email to email@example.com.
Medicinal Chemistry ACS Letters
Deadline: October 31, 2021
Guest Editors: Robert A. Copeland, Accent Therapeutics, Inc., and Associate Editor Donna M. Huryn, University of Pittsburgh
Medicinal Chemistry ACS Letters invites Notes, Letters, Innovations and Technology Notes manuscripts that improve our understanding of chemical modulators of chromatin and RNA modifications. We call on scientists in medicinal chemistry and related fields to contribute their research and innovations to this special issue of the journal.
LEARN MORE: Read Medicinal Chemistry ACS Letters‘Call for Papers Editorial
If you have any questions, please send an email to firstname.lastname@example.org.
ACS Pharmacology and Translation Studies
Deadline: December 31, 2021
Guest Editors: Sanil Bhatia, Heinrich Heine University Düsseldorf; Finn K. Hansen, University of Bonn; and Matthias Schiedel, Friedrich-Alexander University Erlangen-Nuremberg
ACS Pharmacology and Translation Studies invites active researchers to submit manuscripts detailing recent advances in epigenetics, including developing and recommending new tool compounds for epigenetic targets and discovering new biomarkers.
LEARN MORE: Read ACS Pharmacology and Translational Sciences Call for Papers Editorial
If you have any questions, please send an email to email@example.com.
Journal of Medicinal Chemistry
Submission deadlines: July 31, 2021, for Perspectives; October 31, 2021, for articles and remedy notes
The Journal of Medicinal Chemistry invites submissions across the spectrum of epigenetics, including epigenetic studies that focus on human and non-human species. The Journal of Medicinal Chemistry has traditionally been associated with full-length publications reporting substantial studies in medicinal chemistry, and we welcome such submissions. However, we also look forward to shorter preliminary studies that report on work that is highly innovative. We would also like to promote perspectives and remedy comments in the field of epigenetics.
LEARN MORE: read this Journal of Medicinal Chemistry Call for Papers Editorial